Portola Pharmac (PTLA) Misses Q1 EPS by 3c

Portola Pharmac (NASDAQ: PTLA) reported Q1 EPS of ($0.75), $0.03 worse than the analyst estimate of ($0.72). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.81 million.

For earnings history and earnings-related data on Portola Pharmac (PTLA) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• HeartCore Enterprises, Inc. (HTCR) Misses Q2 EPS by 185c
• Cisco rating cut at HSBC as analyst sees a lack of catalysts